The Parkinson-Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease

2005 ◽  
Vol 21 (4) ◽  
pp. 500-509 ◽  
Author(s):  
Alexandre Castro-Caldas ◽  
Paul Delwaide ◽  
Wolfgang Jost ◽  
Marcelo Merello ◽  
Adrian Williams ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Control Study

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

2014 ◽  
Vol 28 (11) ◽  
pp. 1088-1098 ◽  
Author(s):  
Marcos Hortes N Chagas ◽  
Antonio W Zuardi ◽  
Vitor Tumas ◽  
Márcio Alexandre Pena-Pereira ◽  
Emmanuelle T Sobreira ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

Double-blind trial of pergolide for Parkinson's disease

Neurology ◽  
1985 ◽  
Vol 35 (3) ◽  
pp. 291-291 ◽  
Author(s):  
S. G. Diamond ◽  
C. H. Markham ◽  
L. J. Treciokas
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

scholarly journals Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial

2017 ◽  
Vol 379 ◽  
pp. 7-11 ◽  
Author(s):  
Corneliu C. Luca ◽  
Gloria Nadayil ◽  
Chuanhui Dong ◽  
Fatta B. Nahab ◽  
Edelle Field-Fote ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Gait Dysfunction

scholarly journals Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.

1994 ◽  
Vol 33 (9) ◽  
pp. 517-524 ◽  
Author(s):  
Mitsuo TAKAHASHI ◽  
Ryoichi YUASA ◽  
Terukuni IMAI ◽  
Hisao TACHIBANA ◽  
Shiro YORIFUJI ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial
Sign in / Sign up

Export Citation Format

Share Document